Table 1.
The relationship between SNAI2 expression and clinicopathological parameters in 208 primary ovarian cancer from TCGA datasets
| Variables | No. of patients | SNAI2 expression | P value | |
|---|---|---|---|---|
| Low, n(%) | High, n(%) | |||
| Age (years) | 0.325 | |||
| ≤60 | 121 | 57(47.1%) | 64(52.9%) | |
| >60 | 87 | 47(54.0%) | 40(46.0%) | |
| Histologic grade | 0.149 | |||
| G1/G2 | 27 | 17(63.0%) | 10(37.0%) | |
| G3 | 181 | 87(48.1%) | 94(51.9%) | |
| FIGO stage | 0.015 | |||
| I-II | 23 | 17(73.9%) | 6(26.1%) | |
| III-IV | 185 | 87(47.0%) | 98(53.0%) | |
| Lymphatic invasion | 0.004 | |||
| Yes | 130 | 55(42.3%) | 75(57.7%) | |
| No | 78 | 49(62.8%) | 29(37.2%) | |